Drug Patents owned by Galderma Labs

1. List of Clobex drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7700081 GALDERMA LABS Foaming compositions for hair care
Jan, 2022

(1 year, 1 month ago)

Drugs and Companies using CLOBETASOL PROPIONATE ingredient

Market Authorisation Date: 05 February, 2004

Treatment: Topical treatment of scalp psoriasis

Dosage: SHAMPOO;TOPICAL

How can I launch a generic of CLOBEX before it's patent expiration?
More Information on Dosage

2. List of Epiduo Forte drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9814690 GALDERMA LABS Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
Dec, 2022

(a month ago)

US8809305 GALDERMA LABS Administration of adapalene and benzoyl peroxide for the long-term treatment of acne vulgaris
Dec, 2022

(a month ago)

US8445543 GALDERMA LABS Combinations of adapalene and benzoyl peroxide for treating acne lesions
Dec, 2022

(a month ago)

US8785420 GALDERMA LABS Combination/association of adapalene and benzoyl peroxide for treating acne lesions
Dec, 2022

(a month ago)

US8936800 GALDERMA LABS Gel composition for treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
Dec, 2022

(a month ago)

US9381179 GALDERMA LABS Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Mar, 2023

(a month from now)

US8703820 GALDERMA LABS Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Mar, 2023

(a month from now)

US9387187 GALDERMA LABS Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Mar, 2023

(a month from now)

US8729127 GALDERMA LABS Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
Mar, 2023

(a month from now)

Drugs and Companies using ADAPALENE; BENZOYL PEROXIDE ingredient

Market Authorisation Date: 15 July, 2015

Treatment: Treatment of acne

Dosage: GEL;TOPICAL

How can I launch a generic of EPIDUO FORTE before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in